Damora Therapeutics (DMRA) Total Liabilities (2019 - 2026)
Damora Therapeutics (DMRA) posted Total Liabilities of $23.8 million for Q1 2026, up 18.33% on a QoQ basis from $20.1 million in Q4 2025, and up 1339.55% year-over-year from $1.7 million in Q1 2025.
Damora Therapeutics (DMRA) Total Liabilities (2019 - 2026) Analysis & Trends
Damora Therapeutics' Total Liabilities history runs 8 years deep, the most recent figure standing at $23.8 million for Q1 2026.
- Quarterly Total Liabilities rose 1339.55% year-over-year to $23.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $23.8 million (up 1339.55% YoY) and the FY2025 annual result came in at $20.1 million, up 1448.58% from the prior year.
- Total Liabilities was $23.8 million for Q1 2026 at Damora Therapeutics, up from $20.1 million in the prior quarter.
- Across five years, Total Liabilities topped out at $23.8 million in Q1 2026 and bottomed at $1.3 million in Q4 2024.
- A 5-year average of $8.6 million and a median of $7.6 million in 2022 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2024 — Total Liabilities plunged 80.73% — and 2025, when it surged 1448.58%.
- Damora Therapeutics' Total Liabilities stood at $11.4 million in 2022, then slumped by 48.44% to $5.9 million in 2023, then plunged by 77.93% to $1.3 million in 2024, then jumped by 1448.58% to $20.1 million in 2025, then gained by 18.33% to $23.8 million in 2026.
- Business Quant data shows DMRA's Total Liabilities at $23.8 million in Q1 2026, $20.1 million in Q4 2025, and $2.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 60.46 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 177.22 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 3.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 7.33 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 7.12 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 9.45 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 15.48 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.62 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 753.82 Mn |
| 10 | Damora Therapeutics | 1.00 Bn | 798.11 Mn | - | 23.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.84 Mn |
| Dec 31, 2025 | 20.15 Mn |
| Sep 30, 2025 | 2.73 Mn |
| Jun 30, 2025 | 2.74 Mn |
| Mar 31, 2025 | 1.66 Mn |
| Dec 31, 2024 | 1.30 Mn |
| Sep 30, 2024 | 2.44 Mn |
| Jun 30, 2024 | 3.71 Mn |
| Mar 31, 2024 | 4.32 Mn |
| Dec 31, 2023 | 5.90 Mn |
| Sep 30, 2023 | 12.67 Mn |
| Jun 30, 2023 | 15.10 Mn |
| Mar 31, 2023 | 14.30 Mn |
| Dec 31, 2022 | 11.44 Mn |
| Sep 30, 2022 | 9.30 Mn |
| Jun 30, 2022 | 7.79 Mn |
| Mar 31, 2022 | 7.62 Mn |
| Dec 31, 2021 | 4.99 Mn |
| Sep 30, 2021 | 6.25 Mn |
| Jun 30, 2021 | 5.39 Mn |